Pfizer Consumer Healthcare acquired by Johnson & Johnson
Johnson & Johnson acquired Pfizer Consumer Healthcare, an otc consumer health brand, on Dec 20, 2006.
Transaction summary
- Target
- Pfizer Consumer Healthcare
- Acquirer
- Johnson & Johnson
- Seller
- Pfizer
- Announced
- 2006-06-25
- Completed
- 2006-12-20
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-10-21
- Latest update
- 2026-11-03
Value and multiples
100% enterprise value
USD 17B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Reported enterprise value: USD 17bn.
Source summary
Kenvue 10-Q, filed 2025-08-07
ConfirmedAcquisition of Pfizer Consumer Healthcare by Johnson & Johnson.
Open sourceKenvue 10-Q, filed 2025-08-07
ConfirmedIn 2006, J&J acquired Pfizer’s OTC business including the U.S. rights to OTC Zantac, which were on-sold to Boehringer Ingelheim (“BI”) as a condition to merger control approval such that BI assumed product liability risk for U.S. sales from and after December 2006.
Open sourceKenvue 10-Q, filed 2025-08-07
ConfirmedKenvue Inc. (Exact name of registrant as specified in its charter)
Open sourceContinue your research
Related transaction comps
Pfizer Consumer Healthcare acquired by GlaxoSmithKline (GSK-Pfizer consumer joint venture)
2018-12-19 · Estimated
View transaction → Same buyer / investorVogue International LLC acquired by Johnson & Johnson
2016-06-02 · Confirmed
View transaction → Same buyer / investorCi:z Holdings Co., Ltd. acquired by Johnson & Johnson
2018-10-23 · Confirmed
View transaction → Same sellerPfizer Nutrition acquired by Nestlé S.A.
2012-04-23 · Confirmed
View transaction →